臨床試驗

A Study of Photobiomodulation (PBM) Therapy in People With Oral Graft-Versus-Host Disease (GVHD) After Stem Cell Transplant

NCT：NCT05675930 · RECRUITING

NCT IDNCT05675930

狀態RECRUITING

開始日期2022-12-22

完成時間2026-12-22

SponsorMemorial Sloan Kettering Cancer Center (OTHER)

First posted2023-01-09

Last updated2026-05-22

簡要摘要

The purpose of this study is to find out whether photobiomodulation/PBM therapy using the Thor LX2.3 therapy system is a safe and effective treatment for oral Graft-Versus-Host Disease/GVHD.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。